OTCMKTS:ENZC

Enzolytics Competitors

$0.22
0.00 (0.00 %)
(As of 04/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.11
Now: $0.22
$0.24
50-Day Range
$0.17
MA: $0.34
$0.66
52-Week Range
$0.00
Now: $0.22
$0.96
Volume27.92 million shs
Average Volume42.76 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Enzolytics (OTCMKTS:ENZC) Vs. DDXS, TNGN, ATTBF, ACHL, ADTX, and AGNPF

Should you be buying ENZC stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Enzolytics, including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), Achilles Therapeutics plc American Depositary Shares (ACHL), ADiTx Therapeutics (ADTX), and Algernon Pharmaceuticals (AGNPF).

Enzolytics (OTCMKTS:ENZC) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

Valuation and Earnings

This table compares Enzolytics and (DDXS)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EnzolyticsN/AN/AN/AN/AN/A
(DDXS)N/AN/AN/AN/AN/A

Profitability

This table compares Enzolytics and (DDXS)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
EnzolyticsN/AN/AN/A
(DDXS)N/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and price targets for Enzolytics and (DDXS), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Enzolytics0000N/A
(DDXS)0000N/A

Enzolytics (OTCMKTS:ENZC) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

Valuation and Earnings

This table compares Enzolytics and (TNGN)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EnzolyticsN/AN/AN/AN/AN/A
(TNGN)N/AN/AN/AN/AN/A

Profitability

This table compares Enzolytics and (TNGN)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
EnzolyticsN/AN/AN/A
(TNGN)N/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and price targets for Enzolytics and (TNGN), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Enzolytics0000N/A
(TNGN)0000N/A

Enzolytics (OTCMKTS:ENZC) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

Valuation and Earnings

This table compares Enzolytics and Abattis Bioceuticals' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EnzolyticsN/AN/AN/AN/AN/A
Abattis BioceuticalsN/AN/AN/AN/AN/A

Profitability

This table compares Enzolytics and Abattis Bioceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
EnzolyticsN/AN/AN/A
Abattis BioceuticalsN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and price targets for Enzolytics and Abattis Bioceuticals, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Enzolytics0000N/A
Abattis Bioceuticals0000N/A

Enzolytics (OTCMKTS:ENZC) and Achilles Therapeutics plc American Depositary Shares (NASDAQ:ACHL) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

Valuation and Earnings

This table compares Enzolytics and Achilles Therapeutics plc American Depositary Shares' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EnzolyticsN/AN/AN/AN/AN/A
Achilles Therapeutics plc American Depositary SharesN/AN/AN/AN/AN/A

Profitability

This table compares Enzolytics and Achilles Therapeutics plc American Depositary Shares' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
EnzolyticsN/AN/AN/A
Achilles Therapeutics plc American Depositary SharesN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and price targets for Enzolytics and Achilles Therapeutics plc American Depositary Shares, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Enzolytics0000N/A
Achilles Therapeutics plc American Depositary Shares0000N/A

Enzolytics (OTCMKTS:ENZC) and ADiTx Therapeutics (NASDAQ:ADTX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

Valuation and Earnings

This table compares Enzolytics and ADiTx Therapeutics' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EnzolyticsN/AN/AN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/AN/AN/A

Profitability

This table compares Enzolytics and ADiTx Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
EnzolyticsN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and price targets for Enzolytics and ADiTx Therapeutics, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Enzolytics0000N/A
ADiTx Therapeutics00103.00

Summary

ADiTx Therapeutics beats Enzolytics on 1 of the 1 factors compared between the two stocks.

Enzolytics (OTCMKTS:ENZC) and Algernon Pharmaceuticals (OTCMKTS:AGNPF) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

Valuation and Earnings

This table compares Enzolytics and Algernon Pharmaceuticals' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EnzolyticsN/AN/AN/AN/AN/A
Algernon PharmaceuticalsN/AN/AN/AN/AN/A

Profitability

This table compares Enzolytics and Algernon Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
EnzolyticsN/AN/AN/A
Algernon PharmaceuticalsN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and price targets for Enzolytics and Algernon Pharmaceuticals, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Enzolytics0000N/A
Algernon Pharmaceuticals0000N/A

Ad Investing Trends
Elon Musk Signs Australian Pact... Sends One Company Soaring Overnight
Tesla is facing a critical lithium shortage. Could this company be the next Tesla savior?

Enzolytics Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
(DDXS) logo
DDXS
(DDXS)
0.5$0.00-0.0%$0.00N/A0.00
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02-1.6%$0.00N/A0.00
ACHL
Achilles Therapeutics plc American Depositary Shares
0.0$13.73-5.5%$0.00N/A0.00
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.81-2.8%$0.00N/A0.00News Coverage
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.13-7.3%$0.00N/A0.00Increase in Short Interest
Almirall logo
LBTSF
Almirall
0.5$15.00-0.0%$0.00N/A0.00
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.08-0.0%$0.00N/A0.00
ARNI
Arno Therapeutics
0.5$0.01-23.1%$0.00N/A0.00
ASCLF
Ascletis Pharma
0.4$0.37-0.0%$0.00N/A0.00News Coverage
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06-0.0%$0.00N/A0.00Increase in Short Interest
News Coverage
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.60-3.4%$0.00N/A0.00Gap Up
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.52-0.0%$0.00N/A0.00
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.21-6.7%$0.00N/A0.00High Trading Volume
Increase in Short Interest
News Coverage
ORHOF
CannaRoyalty
0.7$9.23-56.1%$0.00N/A0.00Gap Down
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.04-5.5%$0.00N/A0.00Increase in Short Interest
Gap Up
CGYG
China Longyi Group International
0.4$0.00-0.0%$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$22.74-1.0%$0.00N/A0.00Decrease in Short Interest
CELZ
Creative Medical Technology
0.5$0.05-2.3%$0.00N/A0.00Gap Up
Cybin logo
CLXPF
Cybin
1.0$1.46-1.4%$0.00N/A0.00News Coverage
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.00-28.6%$0.00N/A0.00Gap Down
EMMBF
Emblem
0.6$1.40-1.4%$0.00N/A0.00
GB Sciences logo
GBLX
GB Sciences
0.5$0.05-2.1%$0.00N/A0.00Increase in Short Interest
Gap Down
Genfit logo
GNFTF
Genfit
0.5$4.64-0.2%$0.00N/A0.00Decrease in Short Interest
Gap Up
GMXAY
GENMAB A/S/S
0.5$34.65-3.1%$0.00N/A0.00High Trading Volume
Gap Down
Genus logo
GENSF
Genus
0.7$69.40-0.0%$0.00N/A0.00Decrease in Short Interest
News Coverage
HALB
Halberd
0.0$0.04-1.2%$0.00N/A0.00Gap Down
HAVN Life Sciences logo
HAVLF
HAVN Life Sciences
0.0$0.59-1.3%$0.00N/A0.00Decrease in Short Interest
Gap Up
Idorsia logo
IDRSF
Idorsia
0.5$27.18-0.0%$0.00N/A0.00
IPATF
ImmunoPrecise Antibodies
0.5N/AN/A$0.00N/A0.00High Trading Volume
IMLFF
InMed Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Innovation Pharmaceuticals logo
IPIX
Innovation Pharmaceuticals
0.6$0.26-5.8%$0.00N/A0.00News Coverage
Kalytera Therapeutics logo
KALTF
Kalytera Therapeutics
0.6$0.06-36.2%$0.00N/A0.00Increase in Short Interest
Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00-10.0%$0.00N/A0.00Decrease in Short Interest
Mesoblast logo
MEOBF
Mesoblast
0.5$1.72-2.9%$0.00N/A0.00Gap Down
MCURF
Mind Cure Health
0.0$0.34-3.6%$0.00N/A0.00Increase in Short Interest
Mind Medicine (MindMed) logo
MMEDF
Mind Medicine (MindMed)
1.1$2.43-3.7%$0.00N/A0.00
Molecular Partners logo
MLLCF
Molecular Partners
0.5$24.78-1.9%$0.00N/A0.00Gap Down
MPSYF
MorphoSys
0.0$90.50-2.6%$0.00N/A0.00
NRNVF
Nordic Nanovector ASA
0.0$1.64-0.0%$0.00N/A0.00High Trading Volume
Novozymes A/S logo
NVZMF
Novozymes A/S
0.4$66.85-2.4%$0.00N/A0.00
BPSR
Organicell Regenerative Medicine
0.5$0.06-3.5%$0.00N/A0.00Increase in Short Interest
News Coverage
Oxurion logo
TBGNF
Oxurion
0.5$2.75-0.0%$0.00N/A0.00
Pharnext logo
PNEXF
Pharnext
0.0$4.11-0.0%$0.00N/A0.00Decrease in Short Interest
News Coverage
PTEO
Proteo
0.5$0.09-0.0%$0.00N/A0.00
PROT
Proteonomix
0.5$0.01-0.0%$0.00N/A0.00Increase in Short Interest
News Coverage
ProtoKinetix logo
PKTX
ProtoKinetix
0.5$0.18-44.3%$0.00N/A0.00Decrease in Short Interest
News Coverage
PureTech Health logo
PTCHF
PureTech Health
0.0$5.64-1.9%$0.00N/A0.00Decrease in Short Interest
RCPHF
Recipharm AB (publ)
1.0$16.05-0.0%$0.00N/A0.00High Trading Volume
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.